New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in aging populations

Dr. Vadim Jucaud’s lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the…

Continue Reading

News Source: medicalxpress.com